Lung Cancer News

CHICAGO — An ultra-deep sequencing technique detected circulating tumor DNA in plasma at high rates of concordance with tumor tissue among patients with breast, lung and prostate cancers, according to study results presented at the ASCO Annual Meeting.

CHICAGO — Larotrectinib — the first selective small-molecule pan-tropomyosin receptor kinase inhibitor — demonstrated clinical activity in adults and children with various tumors that had neurotrophic tyrosine receptor kinase gene fusions, according to study results presented at the ASCO Annual Meeting.

CHICAGO — An 8-week, web-based stress management program improved quality of life and relieved the distress of patients with cancer, according to a prospective study presented at the ASCO Annual Meeting.

CHICAGO — Patients with metastatic spinal canal compression who received a single radiation dose achieved ambulatory status and OS comparable to those who received a multifraction dose administered over 1 week, according to results of a prospective randomized phase 3 noninferiority trial presented at ASCO Annual Meeting.

Researchers have identified a 30-gene biomarker in the nasal passages of current and former smokers that could help distinguish between benign and malignant lung lesions.

Today’s observance of World No Tobacco Day features the theme, “Tobacco — a threat to development.”

Smoke released from heat-not-burn tobacco cigarettes contains the same harmful components as conventional tobacco cigarette smoke, according to data published in JAMA Internal Medicine.

Gefitinib significantly prolonged DFP compared with standard-of-care chemotherapy in patients with EGFR–positive stage II or IIIa non–small cell lung cancer, according to a phase 3 clinical trial scheduled for presentation at the ASCO Annual Meeting.

An uptake in cancer screening after implementation of the Affordable Care Act in 2014 has shifted the diagnosis of breast, lung and colorectal cancers to an earlier, more treatable stage, according to data scheduled for presentation at the ASCO Annual Meeting.

Robert J. Cerfolio, MD, has been named chief of clinical thoracic surgery at NYU Langone Medical Center.